Skip to content
← Back to this collection

PUBLICATIONS · 12885813

Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2003 Aug 1
First author
Wells RJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Wells RJ
      type
      Author
    2. name
      Adams MT
      type
      Author
    3. name
      Alonzo TA
      type
      Author
    4. name
      Arceci RJ
      type
      Author
    5. name
      Buckley J
      type
      Author
    6. name
      Buxton AB
      type
      Author
    7. name
      Dusenbery K
      type
      Author
    8. name
      Gamis A
      type
      Author
    9. name
      Masterson M
      type
      Author
    10. name
      Vik T
      type
      Author
    11. name
      Warkentin P
      type
      Author
    12. name
      Whitlock JA
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Wells RJ
      type
      Author
    2. name
      Adams MT
      type
      Author
    3. name
      Alonzo TA
      type
      Author
    4. name
      Arceci RJ
      type
      Author
    5. name
      Buckley J
      type
      Author
    6. name
      Buxton AB
      type
      Author
    7. name
      Dusenbery K
      type
      Author
    8. name
      Gamis A
      type
      Author
    9. name
      Masterson M
      type
      Author
    10. name
      Vik T
      type
      Author
    11. name
      Warkentin P
      type
      Author
    12. name
      Whitlock JA
      type
      Author
    bibliography ids
    1. nci-bib-368c4161f4bf525ee329f265
    book metadata
    content sha256
    5e1399c846b633eb83e1f5e0313d3c095cf13117038324b1433d74ab66ab47c5
    document type
    citation
    dois
    1. 10.1200/JCO.2003.06.128
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:12885813
    immutable id
    pubmed:12885813@5e1399c846b633eb83e1f5e0313d3c095cf13117038324b1433d74ab66ab47c5
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    15
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    2940-7
    volume
    21
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      12885813
      provenance
      batch id
      2d0158fe73b50bb1a4bf
      provider
      NCBI PubMed ESummary
      record sha256
      063124a2e9692d35eb07f4b31aa45ef121665f3c2fc1e857a2973429559c69b7
      response sha256
      d46de44782d91ef4394e88a69f82b1ee22148e8c4cf1534eb36c80479345e70e
      retrieved at
      2026-09-09T23:45:50.935339+00:00
      publication date
      display
      2003 Aug 1
      precision
      day
      year
      2003
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Multicenter Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/12885813/
      title
      Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.

      Preserved source evidence · Not medical advice